{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:28:34Z","timestamp":1790227714317,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T023686"],"award-info":[{"award-number":["MR\/T023686"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioadv.2025.214531","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:38:03Z","timestamp":1759347483000},"page":"214531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Enhanced anti-P. aeruginosa treatment via phage and ciprofloxacin co-loaded particles prepared by electrospraying"],"prefix":"10.1016","volume":"180","author":[{"given":"Sai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bolognini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Di Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gaisford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0005","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.3402\/jom.v2i0.5811","article-title":"Respiratory disease and the role of oral bacteria","volume":"2","author":"Gomes-Filho","year":"2010","journal-title":"J. Oral Microbiol."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.47108\/jidhealth.Vol1.Iss1.7","article-title":"Upper respiratory tract infection and otitis media are clinically and microbiologically associated","volume":"1","author":"Hassooni","year":"2018","journal-title":"J. Ideas Health"},{"issue":"6","key":"10.1016\/j.bioadv.2025.214531_rf0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","article-title":"Current challenges and future opportunities of phage therapy","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214531_rf0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2025.214531_bb0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.09.024","article-title":"Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa","volume":"551","author":"Lin","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214531_bb0030","doi-asserted-by":"crossref","first-page":"ftz011","DOI":"10.1093\/femspd\/ftz011","article-title":"P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage\u2013ciprofloxacin combination: monitoring the phage\u2013P. aeruginosa biofilms interactions","volume":"77","author":"Henriksen","year":"2019","journal-title":"Pathog. Dis."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13369-016-2194-3","article-title":"Efficacy of phage and ciprofloxacin co-therapy on the formation and eradication of Pseudomonas aeruginosa biofilms","volume":"42","author":"Sagar","year":"2017","journal-title":"Arab. J. Sci. Eng."},{"key":"10.1016\/j.bioadv.2025.214531_bb0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpb.2019.08.004","article-title":"Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections","volume":"142","author":"Lin","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214531_bb0045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2020.11.019","article-title":"Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation\u2014a proof-of-principle study in a P. aeruginosa lung infection model","volume":"158","author":"Lin","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214531_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119952","article-title":"Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infections","volume":"591","author":"Lin","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214531_bb0055","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/pharmaceutics12040388","article-title":"Investigating the effect of encapsulation processing parameters on the viability of therapeutic viruses in electrospraying","volume":"12","author":"Sanders","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.bioadv.2025.214531_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/02786820802626355","article-title":"Electrospray versus nebulization for aerosolization and filter testing with bacteriophage particles","volume":"43","author":"Eninger","year":"2009","journal-title":"Aerosol Sci. Technol."},{"issue":"8","key":"10.1016\/j.bioadv.2025.214531_bb0065","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1021\/ac802584z","article-title":"Generation of nonagglomerated airborne bacteriophage particles using an electrospray technique","volume":"81","author":"Jung","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bioadv.2025.214531_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2022.117516","article-title":"Effect of freeze drying, spray drying and electrospraying on the morphological, thermal, and structural properties of powders containing phage Felix O1 and activity of phage Felix O1 during storage","volume":"404","author":"Ergin","year":"2022","journal-title":"Powder Technol."},{"issue":"9","key":"10.1016\/j.bioadv.2025.214531_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00607-24","article-title":"Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae","volume":"9","author":"Zhao","year":"2024","journal-title":"Msystems"},{"issue":"7","key":"10.1016\/j.bioadv.2025.214531_bb0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/antibiotics13070680","article-title":"Synergistic antimicrobial effects of phage vB_AbaSi_W9 and antibiotics against Acinetobacter baumannii infection","volume":"13","author":"Choi","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/acsinfecdis.1c00117","article-title":"Synergistic effects of phage\u2013antibiotic combinations against Citrobacter amalonaticus","volume":"8","author":"Manohar","year":"2022","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214531_bb0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol Med Microbiol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0095","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10068-016-0153-0","article-title":"Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus","volume":"25","author":"Jo","year":"2016","journal-title":"Food Sci. Biotechnol."},{"issue":"9","key":"10.1016\/j.bioadv.2025.214531_bb0100","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.xphs.2016.04.024","article-title":"Pharmaceutical applications of electrospraying","volume":"105","author":"Nguyen","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214531_bb0105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/acs.chemmater.0c04634","article-title":"Protocols for reproducible, increased-scale synthesis of engineered particles\u2014bridging the \u201cupscaling gap\u201d","volume":"33","author":"Spoljaric","year":"2021","journal-title":"Chem. Mater."},{"key":"10.1016\/j.bioadv.2025.214531_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.14356\/kona.2010010","article-title":"Producing pharmaceutical particles via electrospraying with an emphasis on nano and nano structured particles-a review","volume":"28","author":"Yurteri","year":"2010","journal-title":"Kona Powder Part. J."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/polym3010131","article-title":"Electrospraying, a reproducible method for production of polymeric microspheres for biomedical applications","volume":"3","author":"Bock","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.bioadv.2025.214531_bb0120","article-title":"Anti-Pseudomonas aeruginosa phage-loaded electrosprayed lactose particles","volume":"106851","author":"Liu","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0125","article-title":"Ciprofloxacin-loaded electrosprayed lactose particles","volume":"2025","author":"Liu","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2008.12.001","article-title":"A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres","volume":"72","author":"Puapermpoonsiri","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214531_bb0135","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/jam.12158","article-title":"Incorporation of T 4 bacteriophage in electrospun fibres","volume":"114","author":"Korehei","year":"2013","journal-title":"J. Appl. Microbiol."},{"issue":"3\u20134","key":"10.1016\/j.bioadv.2025.214531_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.elstat.2007.10.001","article-title":"Electrospraying route to nanotechnology: an overview","volume":"66","author":"Jaworek","year":"2008","journal-title":"J. Electrost."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214531_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/13816128113199990399","article-title":"Application of spray-drying and electrospraying\/electospinning for poorly watersoluble drugs: a particle engineering approach","volume":"20","author":"Bohr","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.bioadv.2025.214531_bb0150","article-title":"Antibiotic prophylaxis in surgery: current insights and future directions for surgical site infection prevention","volume":"15","author":"Dhole","year":"2023","journal-title":"Cureus"},{"issue":"356","key":"10.1016\/j.bioadv.2025.214531_bb0155","doi-asserted-by":"crossref","first-page":"356ra120","DOI":"10.1126\/scitranslmed.aaf4363","article-title":"Treatment of otitis media by transtympanic delivery of antibiotics","volume":"8","author":"Yang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioadv.2025.214531_bb0160","article-title":"Antibiotics and bacterial resistance in the 21st century. Perspectives","volume":"6","author":"Fair","year":"2014","journal-title":"Med. Chem."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214531_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/biomimetics6020031","article-title":"Evaluation of human ear anatomy and functionality by axiomatic design","volume":"6","author":"Sundar","year":"2021","journal-title":"Biomimetics"},{"issue":"3","key":"10.1016\/j.bioadv.2025.214531_bb0170","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pharmaceutics17030392","article-title":"Ciprofloxacin-loaded spray-dried lactose particles: formulation optimization and antibacterial efficacy","volume":"17","author":"Liu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2025.214531_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2013.12.037","article-title":"An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid","volume":"462","author":"Said","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.bioadv.2025.214531_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00383-19","article-title":"PQS produced by the Pseudomonas aeruginosa stress response repels swarms away from bacteriophage and antibiotics","volume":"201","author":"Bru","year":"2019","journal-title":"J. Bacteriol."},{"issue":"11","key":"10.1016\/j.bioadv.2025.214531_bb0185","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1462-2920.2009.02029.x","article-title":"The role of interactions between phage and bacterial proteins within the infected cell: a diverse and puzzling interactome","volume":"11","author":"Roucourt","year":"2009","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0190","series-title":"Bacterial Metabolism","author":"Doelle","year":"2014"},{"issue":"8","key":"10.1016\/j.bioadv.2025.214531_bb0195","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1089\/ars.2011.4051","article-title":"Bacterial adaptation of respiration from oxic to microoxic and anoxic conditions: redox control","volume":"16","author":"Bueno","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.bioadv.2025.214531_bb0200","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/v12101091","article-title":"Phages in anaerobic systems","volume":"12","author":"Hern\u00e1ndez","year":"2020","journal-title":"Viruses"},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2025.214531_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-0934(03)00214-3","article-title":"Study on interaction between T4 phage and Escherichia coli B by microcalorimetric method","volume":"112","author":"Guosheng","year":"2003","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jtbi.2000.2198","article-title":"Understanding bacteriophage therapy as a density-dependent kinetic process","volume":"208","author":"Payne","year":"2001","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2018.02.033","article-title":"Effect of storage temperature on the stability of spray dried bacteriophage powders","volume":"127","author":"Leung","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"48","key":"10.1016\/j.bioadv.2025.214531_bb0220","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/48\/485102","article-title":"Dehydration of bacteriophages in electrospun nanofibers: effect of excipients in polymeric solutions","volume":"27","author":"Koo","year":"2016","journal-title":"Nanotechnology"},{"issue":"22","key":"10.1016\/j.bioadv.2025.214531_bb0225","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/25\/22\/225101","article-title":"Electrospun water-soluble polymer nanofibers for the dehydration and storage of sensitive reagents","volume":"25","author":"Dai","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.bioadv.2025.214531_bb0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003495-200767030-00003","article-title":"The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections","volume":"67","author":"Driscoll","year":"2007","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bioadv.2025.214531_bb0235","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.arcmed.2005.06.009","article-title":"Resistance to antibiotics: are we in the post-antibiotic era?","volume":"36","author":"Alanis","year":"2005","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0240","doi-asserted-by":"crossref","DOI":"10.4161\/bact.24219","article-title":"Phage therapy: should bacterial resistance to phages be a concern, even in the long run?","volume":"3","author":"\u00d6rm\u00e4l\u00e4","year":"2013","journal-title":"Bacteriophage"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/nyas.14533","article-title":"Phage\u2013antibiotic combinations: a promising approach to constrain resistance evolution in bacteria","volume":"1496","author":"North","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0255","doi-asserted-by":"crossref","first-page":"28115","DOI":"10.1038\/srep28115","article-title":"A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections","volume":"6","author":"Danis-Wlodarczyk","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214531_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajme.2015.05.002","article-title":"Bacteriophage-antibiotic synergism to control planktonic and biofilm producing clinical isolates of Pseudomonas aeruginosa","volume":"52","author":"Nouraldin","year":"2016","journal-title":"Alexandria J. Med."},{"key":"10.1016\/j.bioadv.2025.214531_bb0265","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00705-018-3811-0","article-title":"Piperacillin and ceftazidime produce the strongest synergistic phage\u2013antibiotic effect in Pseudomonas aeruginosa","volume":"163","author":"Uchiyama","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123853","article-title":"Optimizing in vitro phage-ciprofloxacin combination formulation for respiratory therapy of multi-drug resistant Pseudomonas aeruginosa infections","volume":"652","author":"Hong","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates","volume":"47","author":"Meletiadis","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214531_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12248-019-0315-0","article-title":"Bacteriophage PEV20 and ciprofloxacin combination treatment enhances removal of Pseudomonas aeruginosa biofilm isolated from cystic fibrosis and wound patients","volume":"21","author":"Chang","year":"2019","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214531_bb0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3920\/BM2020.0132","article-title":"The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?","volume":"12","author":"Fern\u00e1ndez","year":"2021","journal-title":"Benefic. Microbes"},{"issue":"2","key":"10.1016\/j.bioadv.2025.214531_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01714-17","article-title":"Proof-of-principle study in a murine lung infection model of antipseudomonal activity of phage PEV20 in a dry-powder formulation","volume":"62","author":"Chang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214531_bb0295","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Cant\u00f3n","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioadv.2025.214531_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2164(10)70007-1","article-title":"Bacteriophage host range and bacterial resistance","volume":"70","author":"Hyman","year":"2010","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.bioadv.2025.214531_bb0305","series-title":"Ciprofloxacin. StatPearls [internet]","author":"Thai","year":"2023"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214531_bb0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijporl.2007.09.017","article-title":"Pharmacokinetics of CIPRODEX\u00ae otic in pediatric and adolescent patients","volume":"72","author":"Spektor","year":"2008","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214531_bb0315","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejpb.2012.12.022","article-title":"Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections","volume":"84","author":"Vandenheuvel","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214531_bb0320","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1051\/lait:2002025","article-title":"Importance of glass transition and water activity to spray drying and stability of dairy powders","volume":"82","author":"Roos","year":"2002","journal-title":"Lait"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:58:08Z","timestamp":1765213088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825003589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":65,"alternative-id":["S2772950825003589"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214531","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced anti-P. aeruginosa treatment via phage and ciprofloxacin co-loaded particles prepared by electrospraying","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214531"}}